Notices & Policies

Applications for a BRG award should focus on an area of basic, applied, behavioral, or clinical research in bioengineering that supports the missions of the NIH institutes and centers and where progress is likely to make a significant contribution to improving human health.

The purpose of this notice is to change the point of contact for programmatic issues for PAR-03-106 “Innovations in Biomedical Computational Science and Technology” http://grants.nih.gov/grants/guide/pa-files/PAR-03-106.html. Inquiries or contacts concerning institute-specific should be directed to the NIH BISTI technical or financial contacts listed at the following Web site: http://www.bisti.nih.gov/phased-innovation-contacts.cfm. These scientific contacts must also be used to obtain permission to submit applications that request more the $500,000 of direct costs in any year.

This solicitation targets support for fundamental research in biomedical computing science and technology as well as the development and application of new biocomputing tools or technologies for a particular area(s) of scientific opportunity in biomedical research.

purpose of this program announcement is to provide support for investigators working in collaboration with the NIH Roadmap for Medical Research National Centers for Biomedical Computing (NCBC) using the R01 mechanism.

The NIH's success depends on the creativity of investigator-initiated research, much of it supported by the R01 grant mechanism. Many scientists who participated in the development of the NIH Roadmap, however, expressed the view that additional means might be necessary to identify scientists with ideas that have the potential for high impact, but may be too novel, span too diverse a range of disciplines, or be at a stage too early to fare well in the traditional peer review process. A group of distinguished outside consultants proposed that NIH implement a completely new program to encourage highly innovative biomedical research with the great potential to lead to significant advances in human health. This program would complement NIH's traditional, investigator-initiated grant programs. Unlike most NIH grant mechanisms, the NDPA is designed not to support projects but rather to support highly creative and pioneering people.

Bioengineering integrates principles from a diversity of technical and biomedical fields and crosses the boundaries of many scientific disciplines represented throughout academia, laboratories, and industry.

This notice is to inform potential applicants of a change in receipt dates for applications in response to http://grants.nih.gov/grants/guide/pa-files/PAR-04-023.html, “Bioengineering Research Partnerships.”

Through the use of administrative supplements to grants funded by the National Institute of General Medical Sciences(NIGMS), this initiative aims to (a) enhance NIGMS funded research on complex biological processes by bringing to bear approaches from the mathematical, physical, and engineering sciences, (b) recruit established experts from mathematics, physics, engineering, computer science, and other quantitative disciplines into biomedical research, and (c) encourage non-traditional, cross-disciplinary collaborations.

The purpose of this supplemental grant program is to expeditiously provide funds which will enable researchers with existing NIGMS research grants and limited or no other support to complete the high-resolution structure once sufficient preliminary data have been obtained.

The Fogarty International Center (FIC) announces a change of final receipt date for PAR-03-118, the Global Health Research Initiative Program for New Foreign Investigators (GRIP) and the associated Notice (NOT-TW-04-003). The final receipt date for this PAR has been changed to September 21, 2005.

This Notice announces a joint initiative, Interagency Opportunities in Multi-Scale Modeling in Biomedical, Biological, and Behavioral Systems, between three National Science Foundation (NSF) Directorates, eight participating National Institutes of Health (NIH) Institutes, the Bioastronautics Research Division of the National Aeronautics and Space Administration (NASA) and two offices in the U.S. Department of Energy (DOE).

The participating institutes want to share corrections and updates to RFA GM-04-002, Pharmacogenetics Research Network and Knowledge Base.

The National Institute of General Medical Sciences (NIGMS) has changed the receipt dates for applications submitted in response to PAR-03-026, the MARC Ancillary Training Activities grant, from February 1, June 1 and October 1 to January 10 and September 10.

The National Institute of General Medical Sciences (NIGMS) re-announces
the availability of administrative supplements to NIGMS-funded research
grants (R01, R37, P01 and S06) to conduct research with human embryonic
stem cells (HESC).

The National Institute of General Medical Sciences (NIGMS) supports predoctoral and postdoctoral research training in the biomedical sciences under the auspices of the Ruth L. Kirschstein National Research Service Awards (NRSA) Act.

The National Institutes of Health incorrectly stated the receipt and expiration dates for applications submitted in response to two parallel announcements: PAR-03-106, Innovations In Biomedical Computational Science and Technology, and PAR-03-119, Innovations In Biomedical Computational Science and Technology: SBIR/STTR Initiative.

This notice corrects the receipt and expiration dates for applications submitted in response to two parallel announcements: PAR-03-106, Innovations In Biomedical Computational Science and Technology, and PAR-03-119, Innovations In Biomedical Computational Science and Technology: SBIR/STTR Initiative.

The National Institute of General Medical Sciences (NIGMS) has changed the receipt date for applications submitted in response to PAR-00-139, the "Post-Baccalaureate Research Education Program," from December 13, 2003 to October 20, 2003.

The recent winter storms have led to closures of institutions and theFederal Government. The NIH realizes that this may cause problems for investigators who are submitting grant applications for special receipt dates (RFAs and PARs) for the week of February 17, 2003. Applications for special receipt dates that are submitted late because of the recent storms should include a cover letter noting the reasons for the delay.

The purpose of this initiative is to introduce/integrate into the pre- MARC and MARC trainee science curriculum quantitative analytical methods in the study of biological and biomedical processes. The long- term goal of this initiative is to support specific plans for curriculum development leading to an improvement in the quantitative sciences to enhance the academic preparedness of underrepresented minority students in biomedical science fields.

This announcement represents an expansion of the Research Supplements for Underrepresented Minorities program as published in the NIH Guide on April 13, 2001.

The National Institute of General Medical Sciences (NIGMS) and the Division of Mathematical Sciences in the Directorate for Mathematical and Physical Sciences at the National Science Foundation (DMS) plan to support research in mathematics and statistics related to mathematical biology research.

Through the use of administrative supplements to grants funded by theNational Institute of General Medical Sciences(NIGMS), this initiative aims to (1) enhance NIGMS funded research on complex biological processes by bringing to bear approaches from the mathematical, physical, and engineering sciences, (2) recruit established experts from mathematics, physics, engineering, computer science, and other quantitative disciplines into biomedical research, and (3) encourage non-traditional, cross-disciplinary collaborations.

NIGMS has an established interest in understanding interactions of therapeutic drugs or their toxic metabolites with cellular components that may result in the development of toxic effects. This is complementary to the goal of the announcement, namely, the discovery, development and validation of new assays and procedures to determine the toxicological profiles of potential therapeutic drugs.

The National Institute of General Medical Sciences will expand the allowable costs for evaluation projects to grantees of the Minority Opportunities in Research (MORE) Division to include inquiry into factors affecting student outcomes from the programs.

The National Human Genome Research Institute is partnering with the National Institute of General Medical Sciences to expand the MARC U- STAR program to include an emphasis on the Human Genome Program. The purpose of this initiative is to increase the number of underrepresented minority students majoring in disciplines that are relevant to the long-term goals of the Human Genome Project. This initiative is targeted to students majoring in the quantitative sciences and the behavioral and social sciences.

The new (5/2001) PHS 398 and PHS 2590 application kits were developed in response to the mandates of Public Law 106-107, the “Federal Financial Assistance Management Improvement Act of 1999, “ which was enacted on November 20, 1999 and to comply with federal guidance for Electronic Government.

The National Institute of General Medical Sciences, along with the Department of Agriculture, Department of Commerce, Department of Defense, Department of Energy, Environmental Protection Agency, and National Aeronautics and Space Administration, is participating in an interagency funding initiative, led by the National Science Foundation.

The requirement that “Only Principal Investigators (PIs) of NIGMS- funded R01 or R37 grants with two or more years of support remaining at the time of award can serve as a consortium leader” has been changed.

The purpose of this notice is to alert the research community to the participating NIH Institutes’ intention to re-release the Pharmacogenetic Research Network and Database Request for Applications (RFA) for competition in FY2001.

Nanotechnology is emerging as a new field enabling the creation and application of materials, devices, and systems at atomic and molecular levels and the exploitation of novel properties that emerge at the nanometer scale.

Applicants should refer to the May 26, 1999 announcement, “Large-Scale Collaborative Project Awards,” RFA GM-99-007 for instructions and guidelines, http://grants.nih.gov/grants/guide/rfa-files/RFA-GM-99-007.html.  Applicants are also advised to refer to the NIGMS glue grant Web site, http://www.nih.gov/nigms/funding/gluegrants.html, for additional information.  Most importantly, applicants are requested to discuss very early in the planning process the eligibility of their proposed large-scale collaborative project award application with the contacts listed below or their NIGMS program director.

This notice is a revision of the one that appeared in the NIH Guide for Grants and Contracts on September 11, 1992, Vol. 21, No. 33.  This revised notice changes one aspect of that policy that the NIH has implemented.

This notice supersedes the notice that appeared in the NIH Guide for Grants andContracts, Vol. 25, No. 8, March 15, 1996, about the compensation of graduate students with funds from National Institutes of Health (NIH) research grants. The purpose of this notice is to raise the maximum amount provided by NIH research grants for the compensation of a graduate student employee from $23,000 to $26,000.  As before, the amount provided for compensation includes salary or wages, fringe benefits, and tuition remission. 

The National Institutes of Health (NIH) recognizes the value of supporting scientific meetings, conferences, and workshops that are relevant to its scientific mission and to public health. Support of these meetings is contingent on the interests and priorities of the individual Institutes and Centers (I/C) as well as the investment that each I/C determines is appropriate.

For review of MBRS projects, the criteria have been augmented to reflect program-specific considerations. Reviewers will be instructed to address the review criteria below and assign a single, global score for each scored application. The score should reflect the overall impact that the project could have on the field based on consideration of the review criteria.

Beginning with the June 1, 1998 receipt date and thereafter, the National Institutes of Health NIH) will no longer accept applications for the First Independent Research Support and Transition awards (R29).  These awards, also known as FIRST awards, were designed for new investigators.